Cassidy Bio
Cassidy Bio

Cassidy Bio

DR12Ahrefs DR: 12/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent31Agent Readiness: 31/100. Below median. Measured by StartupHub.ai. Median 41.Speed64Site Speed: 64/100. Above median. Measured by Google PageSpeed. Median 62.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

2023Active15

About

Cassidy Bio is an AI-powered company that designs genome editing systems, including guides and editors, by leveraging a genomic foundation model. Their specialized model turns years of trial-and-error into weeks of predictive, therapeutic-grade gene editing design, aiming to make gene editing medicines scalable, predictable, and accessible. They serve the field of gene editing therapeutic development by providing intelligence and predictive tools to accelerate the design process.

Key facts

At-a-glance profile data

Website
cassidybio.com
Founded
2023
Employees
15
Total funding
$20M
Business model
B2B

Funding rounds

Funding rounds raised by Cassidy Bio
DateRoundAmountLead investors
28 Jul 2025Undisclosed round$8M-
1 May 2023Undisclosed round$11MBreakout Ventures
1 May 2023Undisclosed round$1M-

Tech stack

Detected on cassidybio.com, last scanned 27 Sept 2026. Run your own scan

Analytics
Google Tag Manager
CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Google Workspace
Cookie consent
Cookiebot
Add first review

Frequently asked

How much funding has Cassidy Bio raised?

Cassidy Bio has raised a total of $20M in funding.

How many employees does Cassidy Bio have?

Cassidy Bio has approximately 15 people on record.